TherDose

Hyderabad, India Founded: 2003 • Age: 23 yrs Minicorn
Oncology-focused generic and specialty drugs are developed and manufactured.

About TherDose

TherDose is a Healthcare company based in Hyderabad (India) founded in 2003. Oncology-focused generic and specialty drugs are developed and manufactured. It operates on a Direct-to-Consumer (D2C) and Reseller / Distribution model. TherDose has raised $3.98 million across 1 funding round from investors including Hitha Palepu Irrevocable Stock Trust and Robert Pragada Irrevocable Stock Trust. The company has 137 employees. TherDose was last valued at $9.98 million in September 2016. Its Indian entity Therdose Pharma Private Limited reported revenue of β‚Ή26.66 Cr. TherDose offers products and services including Chemotherapy Medicines, Generic Drugs, and Specialty Drugs. Its focus areas include Pharmaceuticals and Oncology Drugs.

Company details

TherDose Pharma Pvt. Ltd. is engaged in the development and delivery of world-class chemotherapy medicines and generics, with a specialization in oncology. The company operates across various therapeutic areas, utilizing rigorous scientific principles through strong in-house research and development. Solutions are provided to diversified global markets, with over 35 generics and specialty drugs developed, alongside numerous dossiers filed in emerging markets. The commitment to affordable pricing is maintained to enhance accessibility to critical treatments.

  • Headquarters Hyderabad, India
  • Employees 137
  • Stage Minicorn
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website therdose.com
  • Social LinkedIn X Facebook
  • Legal Name Therdose Pharma Pvt. Ltd.
  • Date of Incorporation 19 Dec, 2003
  • Jurisdiction Hyderabad, Telangana, India
Key Metrics
  • Annual Revenue
    ₹26.66 Cr

    FY 2025 · +12% YoY

  • Net Loss
    -₹4.90 Cr

    FY 2025 · -18% margin

  • EBITDA
    -₹1.89 Cr

    FY 2025 · -7% margin

  • Total Equity Funding
    $3.98M (USD)

    in 1 rounds

  • Latest Funding Round
    $3.98M (USD), Series A

    Sep 2016

  • Employee Count
    137

Products & Services of TherDose

TherDose offers a comprehensive portfolio of products and services, including Chemotherapy Medicines, Generic Drugs, and Specialty Drugs.

Chemotherapy Medicines
Pharmaceuticals

Chemotherapy medicines are developed for oncology treatment needs.

Generic Drugs
Pharmaceuticals

Generic drugs are produced for various therapeutic areas.

Specialty Drugs
Pharmaceuticals

Specialty drugs are created for specific oncology requirements.

Funding Insights of TherDose

TherDose has successfully raised a total of $3.98M through 1 strategic funding round. The most recent funding activity was a Series A round of $3.98 million completed in September 2016. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $3.98M
  • Total Rounds 1
  • Last Round Series A β€” $3.98M
  • First Round $3.98M

    (Sep 2016)

  • Investors Count 2

All 1 funding rounds of TherDose with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Sep 2016$3.98MSeries A$9.98MHitha Palepu Irrevocable Stock Trust, Robert Pragada Irrevocable Stock Trust
–
Valuation history
DateValuationStage
Sep 2016$9.98Mβ€’β€’β€’β€’β€’β€’β€’β€’

Last known valuation $9.98M (Sep 2016). 2 investors in total: 2 institutional.

Investors in TherDose

TherDose has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Hitha Palepu Irrevocable Stock Trust and Robert Pragada Irrevocable Stock Trust.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
Premium access

Investor details for TherDose

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Board of directors of Therdose Pharma Private Limited (TherDose)

Therdose Pharma Private Limited is the primary company behind TherDose. The board of Therdose Pharma Private Limited currently have 7 directors; the longest-serving is Ratna Sekhar Rao Imadabathuni, appointed in 2021. 16 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Ratna Sekhar Rao Imadabathuni
DIN 00028465
Managing Director12 Nov 20215 yrsTherdose Pharma Private Limited
Meka Kesava Sambasiva Rao
DIN 03622355
Director26 Nov 20214 yrs 11 moTherdose Pharma Private Limited
Arvind Reddy Panyala
DIN 08173737
Director26 Nov 20214 yrs 11 moTherdose Pharma Private Limited
Mahindra Dev Imadabathuni
DIN 08477374
Whole-time director26 Nov 20214 yrs 11 moTherdose Pharma Private Limited
Mantena Raju Narasa
DIN 02666074
Director26 Nov 20214 yrs 11 moTherdose Pharma Private Limited
Raja Vakula Devi Imadabathuni
DIN 00028497
Director03 Oct 20224 yrs 1 moTherdose Pharma Private Limited
Narayana Raju Mantana
DIN 09163239
Director15 Apr 20242 yrs 7 moTherdose Pharma Private Limited

People of TherDose

9 people are tracked at TherDose (4 in leadership, 5 in team); the tracked headcount is 137.

NameRoleGroup
Director OperationsLeadership
I. R. Sekhar Rao
Managing DirectorLeadership
Director MarketingLeadership
M.k. Sambasiva Rao
DirectorLeadership
Srinivas Rao
Dy. Manager -qaTeam
Beeravelli Rajesh
Account AssistantTeam
Praveen Katakam
ChemistTeam
Deepak Mamtora
Assistant ManagerTeam
Ramesh Banothu
Assistant Product ManagerTeam
Premium access

Complete people profiles for TherDose

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Financials of TherDose

Figures of Therdose Pharma Private Limited, the primary company behind TherDose, for FY 2025. Revenue was ₹26.66 Cr (+12% year on year). Net loss was -₹4.90 Cr (-18% margin). EBITDA was -₹1.89 Cr (-7% margin). Revenue has grown at a compounded annual rate of +4% over five years.

  • ₹26.66 CrRevenue · FY 2025 · +12% YoY
  • -₹4.90 CrNet loss · -18% margin
  • -₹1.89 CrEBITDA · -7% margin
  • ₹9.99 CrPaid-up capital
  • 137Employees (provident fund records)
  • +4%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Therdose Pharma Private Limited are on its company page.

Premium access

Detailed financial statements for TherDose

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Timeline of TherDose

3 dated milestones of TherDose across 13 years, from founding to its latest funding, stage changes and deals.

  1. Founded TherDose is founded.
  2. Funding First funding round of $4.0M.
  3. Milestone Reaches Minicorn status.

Top companies in Traditional Health & Nutrition

3 companies that operate in the same segment as TherDose (Traditional Health & Nutrition) in India, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Oral solid drug delivery systems are manufactured and developed.
1985Mumbai, Maharashtra, IndiaUSD 42.49 MUSD 72.52 M1,115
Generic, semi-solid, and liquid dosage forms are manufactured.
1990Bengaluru, Karnataka, IndiaUSD 508.93 M4,050
Specialty generic pharmaceuticals and APIs are manufactured and marketed.
1983Mumbai, Maharashtra, IndiaUSD 6.44 B19,801
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about TherDose

TherDose was founded in 2003 and raised its 1st funding round 13 years after it was founded.

TherDose is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.

TherDose is a funded company, having raised a total of $3.98M across 1 funding round to date. The company's 1st funding round was a Series A of $3.98M, raised on Sep 2016.

TherDose has 137 employees.

The primary company behind TherDose, Therdose Pharma Private Limited, reported revenue of β‚Ή26.66 Cr for FY 2025, up 12% year on year.

TherDose Pharma Pvt. Ltd. is engaged in the development and delivery of world-class chemotherapy medicines and generics, with a specialization in oncology. The company operates across various therapeutic areas, utilizing rigorous scientific principles through strong in-house research and development. Solutions are provided to diversified global markets, with over 35 generics and specialty drugs developed, alongside numerous dossiers filed in emerging markets. The commitment to affordable pricing is maintained to enhance accessibility to critical treatments.

TherDose offers Chemotherapy Medicines, Generic Drugs, and Specialty Drugs.

TherDose has 2 investors. Key investors include Hitha Palepu Irrevocable Stock Trust, and Robert Pragada Irrevocable Stock Trust.

The valuation of TherDose is $9.98M as of Sep 2016.

TherDose operates through Therdose Pharma Private Limited.

The legal entities of TherDose currently have 8 directors, including Meka Kesava Sambasiva Rao, Narayana Raju Mantana, Arvind Reddy Panyala and others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available